HIGHLIGHTS
- who: Jingwei Lin from the Hartford HealthCare, United States University of California, San Francisco have published the research: Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer, in the Journal: (JOURNAL)
- what: Consistently, the study shows that cytochrome P450 pathway is highly expressed in CRPC.
- how: The workflow of the diagnostic model is presented in Figure 1. In the study six genes (HMGN2 MLLT11 SOX4 PCSK1N RGS16 and PTMA) were selected as the input nodes and one indicator (with or without neuroendocrine differentiation) was used as the output . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.